CARPINTERIA, Calif. — Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics, today announced the U.S. Food and Drug Administration (FDA) approval of a new companion diagnostic assay that can reveal whether a patient with advanced non-small cell lung cancer (NSCLC) is likely to respond to a new form of treatment. The […]
Tucson, AZ and Boston, MA — Sunquest Information Systems Inc. and Partners HealthCare today announced the general availability of a new version of GeneInsight, a genetic information solution, to extend the system’s report generation and knowledge management capabilities to exome and genome testing. Developed at the Partners HealthCare Laboratory for Molecular Medicine, a CLIA-certified molecular […]
XIAMEN, China & SAN DIEGO — Amoy Diagnostics Co. Ltd. (ADx) and Illumina, Inc. (NASDAQ: ILMN) today announced a strategic collaboration to accelerate the adoption of precision medicine and targeted therapies in China. Under the collaboration, Amoy will develop and commercialize a series of oncology-related tests based on Illumina’s next-generation sequencing (NGS) platforms, including the […]
DARMSTADT, Germany & NEW YORK — As part of the global strategic alliance between Merck and Pfizer to jointly develop and commercialize avelumab*, an investigational immune checkpoint inhibitor, the companies have announced today that they have a collaboration agreement in place with Dako, an Agilent Technologies company, for the development of a potential companion diagnostic […]
SAN DIEGO & VILLEJUIF, France — Illumina, Inc. (NASDAQ: ILMN), the global leader in DNA sequencing and array-based technologies, today announced it has joined the Worldwide Innovative Networking (WIN) Consortium. Founded on the recognition that greater success can be achieved through collaboration than any organization can achieve alone, the WIN Consortium is a global network […]
MILFORD, Mass. — SeraCare Life Sciences, a leading partner to global in vitro diagnostics manufacturers, announced today that the company’s new precision medicine business unit has launched Seraseq™ HIV-1 Reference Materials; a portfolio consisting of 12 individual high-titer HIV-1 viral isolates that have been characterized by next-generation sequencing (NGS). These products are intended for use […]
Framingham, MA — SCIEX, a global leader in life science analytical technologies, today announced a collaboration with the laboratory of Amanda Paulovich, M.D., Ph.D., at Fred Hutchinson Cancer Research Center, to make Targeted Proteomics in cancer research more reproducible and specific. The collaboration provides SCIEX rights to commercialize the immuno-MRM assays that have been developed […]
San Diego, CA — Nanomed co-founders Ross Bundy and Dr. Brett Goldsmith announce the launch of Nanomedical Diagnostics, Inc., a biotech company developing and commercializing bioelectronics for use in research and diagnostics. Nanomed’s first product, AGILE Research, a label-free, quantitative, low-cost biosensor for small molecule and protein analysis, is entering beta testing this fall and […]
Bandar Seri Begawan, Brunei — Sengenics today announced an exclusive partnership with Diploid, a Belgium-based Human Genome Interpretation service provider to enable more streamlined clinical exome and genome sequencing in the Middle East and GCC countries. Key areas of collaboration include clinical exome and whole genome sequencing, cross-leveraging proprietary mutation databases and clinical interpretation by […]
PROVO, Utah and JABRIYA, Kuwait – Tute Genomics, a leader in clinical sequencing informatics and genomic interpretation technology, today announced a commercial partnership with Genatak, a leading center for genomic medicine in the Middle East. Genatak recently deployed Tute Genomics’ cloud-based platform to advance and scale the center’s genetic diagnostic service, and now plans to […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
